Lovaza Ingredients
Lovaza contains omega-3-acid ethyl esters, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in ethyl ester form, at a total dose of 3600 mg per day (typically four 1-gram capsules), with each gram containing approximately 850-882 mg of combined EPA and DHA in a ratio of approximately 1:1.2. 1
Active Pharmaceutical Ingredients
EPA (Eicosapentaenoic Acid) Ethyl Esters: Lovaza contains EPA as an ethyl ester, which is one of the two primary omega-3 fatty acids in the formulation 2, 3
DHA (Docosahexaenoic Acid) Ethyl Esters: The second major component is DHA, also in ethyl ester form 2, 3
Total Omega-3 Content: The standard dosing provides 3600 mg of omega-3-acid ethyl esters daily, with the EPA and DHA comprising approximately 850-882 mg of the total content per gram 1
EPA to DHA Ratio: The formulation maintains an approximate ratio of 1:1.2 (EPA:DHA) 1
Formulation Characteristics
Ethyl Ester Form: Lovaza uses the ethyl ester formulation of omega-3 fatty acids, which requires pancreatic lipase hydrolysis for absorption 2
Absorption Requirements: Unlike free fatty acid formulations, Lovaza's ethyl ester form requires significant pancreatic lipase stimulation with high-fat meals for adequate intestinal absorption 4
Bioavailability Considerations: The ethyl ester formulation has lower bioavailability during low-fat consumption compared to free fatty acid formulations, with studies showing 4-fold lower absorption under low-fat conditions 4